Tasmania to continue Oracle’s TasVax system for flu and HPV
Tasmania will continue to use the TasVax system from Oracle for other public health-delivered vaccination programs such as the annual flu vaccine and school-based vaccination programs following the well-accepted COVID-19 vaccination system it enabled in just six weeks in early 2021.
The Tasmanian government contracted Oracle on a public good basis – offered by Oracle – to develop a state-wide solution to vaccinations in late 2020, having surveyed the major players. With limited funds, the state decided on a fast procurement process that ruled out a lot of the smaller vendors, but also limited its options in terms of large companies.
Posted in Australian eHealth